Manufacturer: SixPex
Pharmaceutical name: Human Chorionic Gonadotropin
Pack: 1 vial (5000iu)
HCG is a hormone naturally produced by the female placenta during a typical pregnancy. Its mechanism of action closely resembles that of luteinizing hormone (LH), which is known to induce ovulation. When combined with other medications, HCG can be very effective in aiding female patients in achieving pregnancy. Additionally, it may assist male patients experiencing fertility challenges, as treatment with HCG often leads to increased testosterone production.
HCG is frequently prescribed to female patients as part of a treatment plan aimed at: Inducing ovulation in cases of subfertility, generally due to impaired follicle maturation or anovulation. - Supporting the luteal phase. Preparing follicles for retrieval during controlled ovarian hyperstimulation programs (often utilized in medically assisted reproductive techniques).
HCG is also commonly administered to male patients due to its effectiveness in treating Hypogonadotrophic hypogonadism. Some individuals with idiopathic dysspermias have shown positive responses to this treatment. It can also address delayed puberty linked to inadequate functioning of the gonadotrophic pituitary glands and help with cryptorchidism that is not caused by anatomical blockages.
HCG is a well-known medication that assists both male and female patients in overcoming infertility. However, it may also be used for various other medical purposes that are not detailed here.
For female patients considering HCG treatment: As infertile women undergoing assisted reproductive technologies (especially in vitro fertilization) often have tubal abnormalities, there is an increased risk of ectopic pregnancies following treatment with this drug. Therefore, early ultrasound confirmation at the onset of pregnancy to determine if it is intrauterine is critical. Pregnancies resulting from HCG treatment are at a higher risk for multiple gestations. Women with conditions such as thrombosis, severe obesity, or thrombophilia should not use this medication, as they are at heightened risk for arterial or venous thromboembolic events during or after HCG treatment. Additionally, women who have received treatment with this drug may be more susceptible to pregnancy loss.